Motilent
London
About Motilent
Motilent uses medical image analysis to assess digestive diseases. Crohn's disease, irritable bowel syndrome (IBS), and gastroparesis are three of Motilent's main focus areas. The company also supports numerous projects relating to digestive health. New imaging technology created by Motilent is assisting scientists and medical professionals in their understanding of how the digestive system functions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.5M
- Last round: Grant (May 2022)
- Website: motilent.co.uk
Industries & Categories
Health Care, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/motilent-141 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.